{
    "nctId": "NCT04704856",
    "briefTitle": "Supervised Exercise to Promote Infiltration of NK-cells Into the Tumor",
    "officialTitle": "Supervised Exercise to Promote Infiltration of NK-cells Into the Tumor",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 20,
    "primaryOutcomeMeasure": "Participatient Rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* stage I-III breast cancer\n* scheduled for neoadjuvant chemotherapy with 2 or 3-weekly Adriamycin/Cyclofosfamide, followed by Paclitaxel weekly +/- trastuzumab\n* willing to undergo an additional ultrasound guided biopsy\n* ECOG-performance score \u2264 2 (able to perform basic activities of daily living such as walking or biking)\n\nExclusion Criteria:\n\n* addition of immuno- or targeted therapy at start of neoadjuvant chemotherapy\n* currently participating in structured vigorous aerobic exercise and/or resistance exercise\n\n(\u22652 days per week).\n\n* cognitive disorder or severe emotional instability\n* presence of other disabling co-morbidity that might hamper physical exercise e.g. heart failure (NYHA classes 3 and 4), chronic obstructive pulmonary disease (COPD, gold 3 and 4), orthopaedic conditions and neurological disorders (e.g., hernia, paresis, amputation, active rheumatoid arthritis);\n* immunosuppressive medication (e.g. corticosteroids (other than used as part of standard chemotherapy premedication protocol), cyclosporine)\n* immunodeficiency (primary or secondary)\n* impossibility to perform an ultrasound-guided biopsy of the tumor",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}